Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: Life Sci. 2017 Jul 16;185:1–7. doi: 10.1016/j.lfs.2017.07.016

Table 1.

Summary of results.

Time Morphine Sulfate Pellet (25 mg, s.c.) Osmotic Pump (64 mg/mL, 1.0 μL/hour) Subcutaneous injection (20 mg/kg, twice daily)
Plasma Concentration (ng/mL)
24 hours 2695.3±785.1 $ 209.7±50.0 N/A
72 hours 1039.5±73.5 $ 57.3±39.1 N/A
168 hours 229.5±92.5 $ 45.8±25.4 N/A
Antinociception (tail-flick latency, sec)
24 hours 6.4±0.6 $,#,* 2.5±0.2 # 7.9±0.8 *
72 hours 4.2±0.5 # 3.2±0.2 # 7.1±0.4 *
168 hours 3.2±0.3 # 3.5±0.3 # 5.5±0.2 *
Naloxone-precipitated withdrawal (number of jumps)
24 hours 61.4±11.7 * 72.0±16.6 * 35.4±5.1
72 hours 130.6±21.8 #,* 107.8±32.2 * 51.8±12.2 *
168 hours 154.2±21.1 $,#,* 84.6±12.6 * 89.6±12.2 *

Significance is shown as

*

p < 0.05 compared to non-morphine-treated controls,

#

p < 0.05 compared to morphine S.C. injection,

$

p < 0.05 compared to osmotic pump as determined by a two-way ANOVA with a Student-Newman-Keuls post hoc test.